Biofrontera Inc. (BFRI)
USD 0.8
(-4.64%)
USD 0.8
(-4.64%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 4.05 Million USD | 125.57% |
| 2022 | -15.86 Million USD | 35.38% |
| 2021 | -24.54 Million USD | -203.77% |
| 2020 | -8.08 Million USD | -126.15% |
| 2019 | 30.89 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -2.93 Million USD | -185.96% |
| 2024 Q1 | 3.41 Million USD | -15.71% |
| 2023 Q4 | 4.05 Million USD | 767.11% |
| 2023 FY | 4.05 Million USD | 125.57% |
| 2023 Q3 | -608 Thousand USD | 73.07% |
| 2023 Q2 | -2.25 Million USD | 81.64% |
| 2023 Q1 | -12.29 Million USD | 22.48% |
| 2022 Q2 | -31.91 Million USD | -42.29% |
| 2022 Q1 | -22.42 Million USD | 8.62% |
| 2022 FY | -15.86 Million USD | 35.38% |
| 2022 Q4 | -15.86 Million USD | 42.36% |
| 2022 Q3 | -27.51 Million USD | 13.77% |
| 2021 Q2 | -3.05 Million USD | 34.18% |
| 2021 Q4 | -24.54 Million USD | -1330.36% |
| 2021 Q3 | -1.71 Million USD | 43.77% |
| 2021 FY | -24.54 Million USD | -203.77% |
| 2021 Q1 | -4.63 Million USD | 42.61% |
| 2020 FY | -8.08 Million USD | -126.15% |
| 2020 Q4 | -8.08 Million USD | 0.0% |
| 2020 Q1 | 7.3 Million USD | 0.0% |
| 2019 FY | 30.89 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 435.33 Million USD | 99.068% |
| Embecta Corp. | 1.31 Billion USD | 99.691% |
| ANI Pharmaceuticals, Inc. | 94.2 Million USD | 95.695% |
| Dynavax Technologies Corporation | 106.63 Million USD | 96.196% |
| Esperion Therapeutics, Inc. | 458.69 Million USD | 99.116% |
| Pacira BioSciences, Inc. | 432.74 Million USD | 99.063% |
| PainReform Ltd. | -7.95 Million USD | 151.019% |
| Aquestive Therapeutics, Inc. | 74.95 Million USD | 94.588% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 125.942% |
| SCYNEXIS, Inc. | -19.35 Million USD | 120.961% |
| China SXT Pharmaceuticals, Inc. | -9.42 Million USD | 143.013% |
| Cosmos Health Inc. | 8.59 Million USD | 52.786% |
| Journey Medical Corporation | -9.7 Million USD | 141.776% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 125.942% |
| Safety Shot Inc | -2.28 Million USD | 277.554% |
| Alpha Teknova, Inc. | 1.97 Million USD | -105.471% |
| Intra-Cellular Therapies, Inc. | -130.82 Million USD | 103.1% |
| Bright Green Corporation | 1.84 Million USD | -120.228% |
| Procaps Group, S.A. | 242.93 Million USD | 98.33% |
| Theratechnologies Inc. | 24.87 Million USD | 83.692% |
| Harrow Health, Inc. | 116.41 Million USD | 96.516% |
| Sonoma Pharmaceuticals, Inc. | -2.52 Million USD | 260.952% |
| DURECT Corporation | -7.65 Million USD | 152.992% |
| Supernus Pharmaceuticals, Inc. | -33.52 Million USD | 112.098% |
| Cronos Group Inc. | -663.32 Million USD | 100.611% |
| OptiNose, Inc. | 58.06 Million USD | 93.015% |
| Ironwood Pharmaceuticals, Inc. | 623.38 Million USD | 99.349% |
| Kala Pharmaceuticals, Inc. | -14.57 Million USD | 127.834% |
| RedHill Biopharma Ltd. | -5.18 Million USD | 178.21% |
| Organogenesis Holdings Inc. | 15.01 Million USD | 72.983% |
| Guardion Health Sciences, Inc. | -6.35 Million USD | 163.777% |
| Cumberland Pharmaceuticals Inc. | 106.85 Thousand USD | -3695.656% |
| Radius Health, Inc. | 359.28 Million USD | 98.871% |
| Universe Pharmaceuticals INC | 197.2 Thousand USD | -1956.701% |
| ProPhase Labs, Inc. | 19.23 Million USD | 78.909% |
| Phibro Animal Health Corporation | 454.84 Million USD | 99.108% |
| Procaps Group S.A. | 242.93 Million USD | 98.33% |
| Alvotech | 1.06 Billion USD | 99.619% |
| TherapeuticsMD, Inc. | 3.67 Million USD | -10.277% |
| Viatris Inc. | 17.13 Billion USD | 99.976% |
| Rockwell Medical, Inc. | 4.45 Million USD | 8.977% |
| Aytu BioPharma, Inc. | -4.87 Million USD | 183.166% |
| SIGA Technologies, Inc. | -148.68 Million USD | 102.728% |
| Tilray Brands, Inc. | 158.97 Million USD | 97.449% |
| Lifecore Biomedical, Inc. | 121.89 Million USD | 96.673% |
| Shineco, Inc. | 29.29 Million USD | 86.152% |
| PetIQ, Inc. | 351.93 Million USD | 98.848% |
| Regencell Bioscience Holdings Limited | -2.9 Million USD | 239.793% |
| Incannex Healthcare Limited | -5.48 Million USD | 173.947% |
| Neurocrine Biosciences, Inc. | 177.3 Million USD | 97.712% |
| Alimera Sciences, Inc. | 55.3 Million USD | 92.667% |
| Silver Spike Investment Corp. | -32.61 Million USD | 112.437% |
| Assertio Holdings, Inc. | -32.52 Million USD | 112.469% |
| Shuttle Pharmaceuticals Holdings, Inc. | -1.48 Million USD | 372.448% |
| Petros Pharmaceuticals, Inc. | -5.06 Million USD | 180.152% |
| Clever Leaves Holdings Inc. | -4.81 Million USD | 184.254% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 149.382% |
| Avadel Pharmaceuticals plc | 4.21 Million USD | 3.818% |
| Hempacco Co., Inc. | 13.61 Million USD | 70.209% |
| Talphera, Inc. | -5.72 Million USD | 170.897% |
| Alvotech | 1.06 Billion USD | 99.619% |
| Eagle Pharmaceuticals, Inc. | 7.14 Million USD | 43.233% |
| Lantheus Holdings, Inc. | -96.71 Million USD | 104.194% |
| Currenc Group, Inc. | -16.57 Million USD | 124.473% |
| Kamada Ltd. | -46.43 Million USD | 108.735% |
| Indivior PLC | -33.95 Million USD | 111.946% |
| Evoke Pharma, Inc. | 260.57 Thousand USD | -1456.564% |
| Flora Growth Corp. | -713 Thousand USD | 668.864% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 149.382% |
| Evolus, Inc. | 63.7 Million USD | 93.633% |
| HUTCHMED (China) Limited | -197.45 Million USD | 102.054% |
| Amphastar Pharmaceuticals, Inc. | 479.11 Million USD | 99.153% |
| Akanda Corp. | 3.9 Million USD | -3.869% |